Liu, X.; Balaraman, K.; Lynch, C.C.; Hebron, M.; Wolf, C.; Moussa, C.
Novel Ubiquitin Specific Protease-13 Inhibitors Alleviate Neurodegenerative Pathology. Metabolites 2021, 11, 622.
https://doi.org/10.3390/metabo11090622
AMA Style
Liu X, Balaraman K, Lynch CC, Hebron M, Wolf C, Moussa C.
Novel Ubiquitin Specific Protease-13 Inhibitors Alleviate Neurodegenerative Pathology. Metabolites. 2021; 11(9):622.
https://doi.org/10.3390/metabo11090622
Chicago/Turabian Style
Liu, Xiaoguang, Kaluvu Balaraman, Ciarán C. Lynch, Michaeline Hebron, Christian Wolf, and Charbel Moussa.
2021. "Novel Ubiquitin Specific Protease-13 Inhibitors Alleviate Neurodegenerative Pathology" Metabolites 11, no. 9: 622.
https://doi.org/10.3390/metabo11090622
APA Style
Liu, X., Balaraman, K., Lynch, C. C., Hebron, M., Wolf, C., & Moussa, C.
(2021). Novel Ubiquitin Specific Protease-13 Inhibitors Alleviate Neurodegenerative Pathology. Metabolites, 11(9), 622.
https://doi.org/10.3390/metabo11090622